GEHC Stock Analysis: Buy, Sell, or Hold?
GEHC - GE HealthCare Technologies Inc. Common Stock
$78.97
0.19 (0.24%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 04, 2026
3d
Get Alerted When GEHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: GEHC shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: GEHC shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$109.89
Based on 6.1% avg growth
INTRINSIC VALUE TODAY
$68.23
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GEHC is currently trading at $78.97, which is considered oversold relative to its 30-day fair value range of $80.24 to $85.60. The stock's valuation (Forward PE: 16.0) is in line with its historical norms (16.6). Remarkably, the market is currently pricing in an annual earnings decline of 1.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, GEHC is in a strong uptrend. The price is currently testing key support at $77.67. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $92.00 (+16.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GEHC is in a strong uptrend. The price is currently testing key support at $77.67. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $92.00 (+16.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$80.24 -
$85.60
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($92.00)
Fair Price Analysis
30-Day Fair Range
$80.24 -
$85.60
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$77.67
Resistance Level
$83.21
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
15.99
Wall Street Target
$92.00
(+16.8%)
Revenue Growth (YoY)
5.8%
Earnings Growth (YoY)
-4.1%
Profit Margin
10.9%
Valuation Discount vs History
-1.3% cheaper
PE vs Historical
16.0 vs 16.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.3%
(market-implied from PE analysis)
1-Year Target
$77.76
(-1%)
2-Year Target
$76.75
(-3%)
3-Year Target
$75.75
(-4%)
3-Yr Target (if PE normalizes)
(PE: 16→17)
$78.62
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 8.2%)
$139.27
(+77%)
Base:
(SPY PE: 16.0, Growth: 8.2%)
$99.88
(+27%)
Bear:
(PE: 13.6, Growth: 8.2%)
$84.90
(+8%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 16.41 | Current EPS (TTM): $4.83
Bull Case
$88.92
(+13%)
Analyst growth 2.0%, PE expands to 18.1
Base Case
$80.84
(+2%)
Market implied 2.0%, PE stable at 16.4
Bear Case
$53.90
(-32%)
Severe decline -20.0%, PE contracts to 14.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.0 to 16.6
Stabilization Target:
$81.77
(+3.8%)
PE Expansion Potential:
+3.8%
Last updated: January 30, 2026 10:05 PM ET
Data refreshes hourly during market hours. Next update: 11:05 PM
Data refreshes hourly during market hours. Next update: 11:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GEHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced GEHC Option Strategies
Professional options setups generated by AI based on today's GEHC price and gamma walls.
